Abiopharma

Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting

(30% Negative) INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Reports Q4 2025 Financial Results

(10% Negative) BIOGEN INC. (BIIB) Reports Q4 2025 Financial Results

LOWENTHAL GARRY N 🟢 acquired 75.0K shares of PetVivo Holdings, Inc. (PETV) at $1.27 Transaction Date: Oct 23, 2025 | Filing ID: 020129

(90% Positive) Takeda Pharmaceutical Co., Ltd. (TKPHF) Reports Q4 2025 Financial Results (Form 6-K)

New Form DEF 14A - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Filed: 2025-10-30 AccNo: 0001477932-25-007803 Size: 1 MB

(10% Negative) Takeda Pharmaceutical Co., Ltd. (TKPHF) Reports Q4 2025 Financial Results (Form 6-K)

New Form 8-K/A - Wave Life Sciences Ltd. Filed: 2025-10-30 AccNo: 0001193125-25-257298 Size: 198 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

(90% Positive) Immutep Limited (IMMP) Files Form 6-K

(10% Negative) Takeda Pharmaceutical Co., Ltd. (TKPHF) Reports Q4 2025 Financial Results (Form 6-K)

Director Lai John 🟢 acquired 75.0K shares of PetVivo Holdings, Inc. (PETV) at $1.27 Transaction Date: Oct 23, 2025 | Filing ID: 020122

General Announcement: Appointment of Deputy Chief Executive Officers

Integra LifeSciences Reports Third Quarter 2025 Financial Results

Amneal Reports Third Quarter 2025 Financial Results

IFF Honors Distinguished Academics Shaping the Future of Nutrition, Health and Biosciences